These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26136746)

  • 1. Can Selective MHC Downregulation Explain the Specificity and Genetic Diversity of NK Cell Receptors?
    Carrillo-Bustamante P; Kesmir C; de Boer RJ
    Front Immunol; 2015; 6():311. PubMed ID: 26136746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Coevolutionary Arms Race between Hosts and Viruses Drives Polymorphism and Polygenicity of NK Cell Receptors.
    Carrillo-Bustamante P; Keşmir C; de Boer RJ
    Mol Biol Evol; 2015 Aug; 32(8):2149-60. PubMed ID: 25911231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution of natural killer cell receptors.
    Carrillo-Bustamante P; Keşmir C; de Boer RJ
    Immunogenetics; 2016 Jan; 68(1):3-18. PubMed ID: 26392015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS.
    Iannello A; Debbeche O; Samarani S; Ahmad A
    J Leukoc Biol; 2008 Jul; 84(1):1-26. PubMed ID: 18388298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ly49 receptors: evolution, genetic diversity, and impact on immunity.
    Rahim MM; Makrigiannis AP
    Immunol Rev; 2015 Sep; 267(1):137-47. PubMed ID: 26284475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic investigation of MHC-independent missing-self recognition by mouse NK cells using an in vivo bone marrow transplantation model.
    Chen P; Aguilar OA; Rahim MM; Allan DS; Fine JH; Kirkham CL; Ma J; Tanaka M; Tu MM; Wight A; Kartsogiannis V; Gillespie MT; Makrigiannis AP; Carlyle JR
    J Immunol; 2015 Mar; 194(6):2909-18. PubMed ID: 25681346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of human herpes virus type 8-associated diseases by NK cells.
    Sirianni MC; Campagna M; Scaramuzzi D; Carbonari M; Toschi E; Bacigalupo I; Monini P; Ensoli B
    Ann N Y Acad Sci; 2007 Jan; 1096():37-43. PubMed ID: 17405914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral MHC class I-like molecule allows evasion of NK cell effector responses in vivo.
    Pyzik M; Dumaine A; Charbonneau B; Fodil-Cornu N; Jonjic S; Vidal SM
    J Immunol; 2014 Dec; 193(12):6061-9. PubMed ID: 25392524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Licensed and Unlicensed NK Cells: Differential Roles in Cancer and Viral Control.
    Tu MM; Mahmoud AB; Makrigiannis AP
    Front Immunol; 2016; 7():166. PubMed ID: 27199990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire.
    Held W; Dorfman JR; Wu MF; Raulet DH
    Eur J Immunol; 1996 Oct; 26(10):2286-92. PubMed ID: 8898935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cytolytic T lymphocytes expressing HLA class-I-specific inhibitory receptors.
    Mingari MC; Pietra G; Moretta L
    Curr Opin Immunol; 2005 Jun; 17(3):312-9. PubMed ID: 15886123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying the Protection of Activating and Inhibiting NK Cell Receptors during Infection with a CMV-Like Virus.
    Carrillo-Bustamante P; Keşmir C; de Boer RJ
    Front Immunol; 2014; 5():20. PubMed ID: 24523722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza Virus Targets Class I MHC-Educated NK Cells for Immunoevasion.
    Mahmoud AB; Tu MM; Wight A; Zein HS; Rahim MM; Lee SH; Sekhon HS; Brown EG; Makrigiannis AP
    PLoS Pathog; 2016 Feb; 12(2):e1005446. PubMed ID: 26928844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Higher Frequency of NKG2A+ than of NKG2A- NK Cells Responds to Autologous HIV-Infected CD4 Cells irrespective of Whether or Not They Coexpress KIR3DL1.
    Lisovsky I; Isitman G; Song R; DaFonseca S; Tremblay-McLean A; Lebouché B; Routy JP; Bruneau J; Bernard NF
    J Virol; 2015 Oct; 89(19):9909-19. PubMed ID: 26202228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour MHC class I downregulation and immunotherapy (Review).
    Bubeník J
    Oncol Rep; 2003; 10(6):2005-8. PubMed ID: 14534734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the Ly49A gene in murine natural killer cell clones is predominantly but not exclusively mono-allelic.
    Held W; Raulet DH
    Eur J Immunol; 1997 Nov; 27(11):2876-84. PubMed ID: 9394813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex.
    Yokoyama WM; Seaman WE
    Annu Rev Immunol; 1993; 11():613-35. PubMed ID: 8476574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of MHC class I receptors confers functional intraclonal heterogeneity to a reactive expansion of gammadelta T cells.
    Lafarge X; Pitard V; Ravet S; Roumanes D; Halary F; Dromer C; Vivier E; Paul P; Moreau JF; Déchanet-Merville J
    Eur J Immunol; 2005 Jun; 35(6):1896-905. PubMed ID: 15864777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity.
    Vilches C; Parham P
    Annu Rev Immunol; 2002; 20():217-51. PubMed ID: 11861603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
    Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.